Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the …
G Lemesle, G Schurtz, T Meurice, O Tricot, N Lemaire… - Cardiology, 2016 - karger.com
Background: Clopidogrel use as single antiplatelet therapy (SAPT) has never been
evaluated in stable coronary artery disease (CAD) outpatients either as compared to …
evaluated in stable coronary artery disease (CAD) outpatients either as compared to …
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients
CT Chin, WE Boden, MT Roe, B Neely, ML Neely… - Heart, 2016 - heart.bmj.com
Objective We investigated whether prior clopidogrel influenced long-term ischaemic and
bleeding risks and modified the randomised treatment effect of clopidogrel versus prasugrel …
bleeding risks and modified the randomised treatment effect of clopidogrel versus prasugrel …
Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness …
Objectives The clinical significance of the laboratory-based phenomenon of clopidogrel
hypo-responsiveness and platelet reactivity associated with acute myocardial infarction …
hypo-responsiveness and platelet reactivity associated with acute myocardial infarction …
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
P Lindgren, U Stenestrand, K Malmberg, B Jönsson - Clinical therapeutics, 2005 - Elsevier
BACKGROUND:: The Percutaneous CoronaryIntervention-Clopidogrel in Unstable Angina
to Prevent Recurrent Events (PCI-CURE) study, which examined the effect of adding …
to Prevent Recurrent Events (PCI-CURE) study, which examined the effect of adding …
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and …
Z Motovska, P Widimsky, R Petr, D Bilkova… - Journal of …, 2009 - journals.lww.com
Purpose: The aim was to identify factors that influence the efficacy of 600 mg of clopidogrel
pretreatment in patients with stable coronary artery disease undergoing elective …
pretreatment in patients with stable coronary artery disease undergoing elective …
Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis
Despite the growing use of clopidogrel, limited data exist regarding the prognostic
significance of chronic clopidogrel therapy in patients sustaining acute coronary syndrome …
significance of chronic clopidogrel therapy in patients sustaining acute coronary syndrome …
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable …
Background—We studied the benefits and risks of adding clopidogrel to different doses of
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
Long-term combination therapy with aspirin and clopidogrel
CR Kumana, G Cheung, IJ Lauder… - Journal of …, 2004 - journals.sagepub.com
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in
the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management …
the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management …
Comparison of the impact of short (< 1 year) and long-term (≥ 1 year) clopidogrel use following percutaneous coronary intervention on mortality
S Banerjee, C Varghese, J Samuel… - The American journal of …, 2008 - Elsevier
The optimal duration of clopidogrel administration after percutaneous coronary intervention
(PCI) remains unknown. Clopidogrel is currently recommended for minimums of 1 and 12 …
(PCI) remains unknown. Clopidogrel is currently recommended for minimums of 1 and 12 …
Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention
B Zhu, Z Zhao, P McCollam, J Anderson… - … medical research and …, 2011 - Taylor & Francis
Objective: Recent guidelines recommend use of aspirin and either clopidogrel or prasugrel
for at least 12 months following use of drug-eluting or bare metal stents in patients with acute …
for at least 12 months following use of drug-eluting or bare metal stents in patients with acute …